|
Gender (M:F)
|
8:10
|
|
Age at recruitment (years)
|
17.7 (1.9)
|
|
Age of onset (years)
|
13.9 (3.0)
|
|
Polarity of index episode (%) d, D, m, M
|
61, 22, 0, 17
|
|
Duration of illness (years)
|
3.4 (2.7)
|
|
Most recent mood episode (%) D, m, M
|
33, 45, 22
|
|
Bipolar Diagnosis (%)
| |
|
BPI
|
22
|
|
BPII
|
11
|
|
BPNOS
|
67
|
|
Lifetime Psychotic Features (%)
|
61
|
|
Hospitalization Ever (%)
|
44
|
|
Clinical Course (%)
| |
|
Episodic
|
11
|
|
Non-Episodic
|
89
|
|
Comorbid Disorders (%)
| |
|
Anxiety
|
33
|
|
ADHD
|
22
|
|
Sleep
|
17
|
|
None
|
22
|
|
Mean quetiapine dose over the study (SD)
|
340.9 mg (276.5)
|
|
Mean quetiapine dose at study end (SD)
|
294.6 mg (267.3)
|
